SLGL
- Sol-Gel Technologies Ltd.
()
Overview
Company Summary
Sol-Gel Technologies Ltd. (SLGL) is a specialty pharmaceutical company that focuses on developing and commercializing innovative topical dermatological drug products. The company utilizes its proprietary technology, which is based on the sol-gel process, to enhance the delivery of various active pharmaceutical ingredients (APIs) to the skin.
The sol-gel process involves the conversion of a liquid precursor into a gel-like substance that can be applied topically. Sol-Gel Technologies applies this process to develop advanced drug products with controlled-release properties, improved bioavailability, and extended therapeutic effects.
The company's main goal is to address unmet needs in the field of dermatology by developing safer, more effective, and patient-friendly topical treatments. They focus on various skin conditions such as acne, rosacea, and seborrheic dermatitis, as well as more complex diseases like psoriasis and atopic dermatitis. Sol-Gel Technologies also targets common conditions like molluscum contagiosum and actinic keratosis.
By leveraging their expertise in sol-gel technology and collaborative partnerships with dermatology experts, Sol-Gel Technologies aims to improve patients' quality of life and provide healthcare professionals with innovative treatment options. Their products are developed to be easy to use, enhance patient compliance, and address specific needs such as sustained release and controlled dosing.
Overall, Sol-Gel Technologies is dedicated to developing and offering advanced topical dermatological drug products with improved efficacy and safety profiles, contributing to the advancement of dermatological care.